Search

everythinglearnresearchcommunity

for

Search:↓

Actinic keratosis is more common in older men with certain genetic traits, but smoking seems to reduce its odds.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Topical tofacitinib is effective and safe for treating alopecia areata.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Topical metformin effectively treats melasma with minimal side effects.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Topical flutamide works as well as hydroquinone for melasma but needs more safety checks.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

People with alopecia who are more resilient tend to feel less stressed.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Higher anxiety levels are linked to sexual dysfunction in women with PCOS.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

PRP is an effective and safe treatment for hair loss in women.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.